FDA Approved: ELTROMBOPAG — Original Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a generic eltrombopag product under an original application (ANDA 206788) submitted by XLCare Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

ORIG AP for ELTROMBOPAG (ELTROMBOPAG)